10x Genomics Inc. (TXG)
NASDAQ: TXG
· Real-Time Price · USD
12.06
-0.43 (-3.44%)
At close: Sep 24, 2025, 3:59 PM
12.29
1.91%
After-hours: Sep 24, 2025, 07:25 PM EDT
-3.44% (1D)
| Bid | 12 |
| Market Cap | 1.5B |
| Revenue (ttm) | 644.47M |
| Net Income (ttm) | -84.6M |
| EPS (ttm) | -0.7 |
| PE Ratio (ttm) | -17.23 |
| Forward PE | -13.01 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 12.62 |
| Volume | 2,484,410 |
| Avg. Volume (20D) | 3,213,774 |
| Open | 12.52 |
| Previous Close | 12.49 |
| Day's Range | 11.96 - 12.65 |
| 52-Week Range | 6.78 - 23.07 |
| Beta | 2.00 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for TXG stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts10x Genomics Inc. is scheduled to release its earnings on
Oct 28, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-3.98%
TXG stock has given up its prior gain. 10x Genomic...
Unlock content with
Pro Subscription
1 month ago
-3.98%
10x Genomics shares are trading higher after the company reported better-than-expected Q2 financial results and announced it will acquire Scale Biosciences. Also, Barclays raised its price target on the stock from $13 to $15.
1 month ago · 247wallst.com
2 Growth Stocks Cathie Wood Is Buying Non-StopCathie Wood is most known for her bold, tech-first investing.
